🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to assess the non-inferior antiviral activity ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-01
Trial ID
NCT01263015
The purpose of this trial is to assess the non-inferior antiviral activity ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-19
Trial ID
NCT01227824
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of a fixed ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-11-13
Trial ID
NCT02607930
Treatments Being Tested
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
Mills Clinical Research
Start Date
2017-05-09
Trial ID
NCT03060447
Treatments Being Tested
This is a phase 2b, randomized, multicenter, parallel group, partially blin...
Status
Terminated
Location
GSK Investigational Site
Start Date
2020-11-18
Trial ID
NCT04493216
Treatments Being Tested
This study will evaluate the efficacy of switching from emtricitabine/tenof...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-05-06
Trial ID
NCT02121795
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of switchin...
Status
Completed
Location
Multiple Locations
Start Date
2015-11-11
Trial ID
NCT02603120
Treatments Being Tested
Introduction An increase in cardiovascular disease (CVD) among people livin...
Status
Suspended
Location
Mwananyamala Regional Referral Hospital, Mbagala Rangi Tatu Hospital
Start Date
2020-03-02
Trial ID
NCT05525156
Treatments Being Tested
Dolutegravir (DTG, GSK1349572 is an integrase inhibitor that is currently i...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-12
Trial ID
NCT01498861
Treatments Being Tested
To investigate the pharmacokinetic drug-drug interaction potential of fixed...
Status
Completed
Location
Multiple Locations
Start Date
2016-02-23
Trial ID
NCT02556268